Fundz

Granza Bio raised over $7M in Seed funding led by Felicis and Refactor to expand operations and development efforts.

PRIVATEJul 04, 2024

Amount Raised

$7 Million

Round Type

Seed

San FranciscoBiotechnology

Investors

Joel MeyerWill OlsenYotam RosenbaumBenjamin BryantEoghan MccabeEli BrownEric EldonEric MigicovskyJJ FliegelmanRichard AbermanNorth South VenturesOxford Angel FundPioneer FundRitual CapitalZeno VenturesMetaplanetY CombinatorRefactorFelicis

Description

Granza Bio, a San Francisco, CA-based therapeutic delivery platform developer, raised over $7M in Seed funding led by Felicis and Refactor, with participation from several other investors. The company intends to use the funds to expand operations and its development efforts.

Quick answer

Granza Bio raised $7 Million in a Seed round, dated July 4, 2024. Investors: Joel Meyer, Will Olsen, Yotam Rosenbaum, Benjamin Bryant, Eoghan Mccabe, Eli Brown, Eric Eldon and Eric Migicovsky. Granza Bio is based in San Francisco, California, United States.

How much did Granza Bio raise?
Granza Bio raised $7 Million in a Seed round on July 4, 2024.
Who invested in Granza Bio?
Joel Meyer, Will Olsen, Yotam Rosenbaum, Benjamin Bryant, Eoghan Mccabe, Eli Brown, Eric Eldon and Eric Migicovsky are named as investors in this round.
What does Granza Bio do?
Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues.
Where is Granza Bio based and how big is it?
Granza Bio is based in San Francisco, California, United States.
Who are the decision-makers at Granza Bio?
Fundz holds 1 contact at Granza Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Granza Bio that raised within 45 days of this round, from Fundz verified event records.

  • Savran Technologies raised $425K (Seed) on August 16, 2024.
  • MolecuLight raised $12M (Series C) on August 16, 2024.
  • Neochord raised $914K (Seed) on August 16, 2024.
  • Revolution-ZERO raised $321K (Funding Round) on August 16, 2024.
  • Jupiter Endovascular raised $21M (Funding Round) on August 15, 2024.
  • Hexarad raised $14M (Funding Round) on August 15, 2024.

Who to call at Granza Bio, and when

A new round usually means Granza Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Granza Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Granza Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Granza Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Granza Bio

Location

San Francisco, California, United States

About

Granza Bio is a biotechnology company developing a novel delivery “shell” platform to direct therapeutic cargo to specific tissues. For their lead candidate, Granza Bio is leveraging the discovery of the immune system’s powerful suite of weapons, “attack particles”. Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Granza Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Granza Bio's next move

See what Strategic adds

Granza Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.